Ceesay Abraham

Chief Executive Officer, DirectorRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Oct 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$282K
Net Open-Market Flow
-$282K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Sell(S)1K$26.14$31K580K
Oct 15, 2025Sell(S)5K$25.72$120K581K
Oct 15, 2025Sell(S)4K$25.75$111K42K
Oct 15, 2025Sell(S)755$26.17$20K41K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-241472) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RAPP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-25-241472"
Ask your agent
Use Arkolith to summarize insider buying and selling at Rapport Therapeutics, Inc.
over the last 90 days and cite the filings.